dc.contributor.author | Cardella, D | |
dc.contributor.author | Sanchez-Guzman, D | |
dc.contributor.author | Rabbitts, TH | |
dc.date.accessioned | 2023-11-30T14:06:55Z | |
dc.date.available | 2023-11-30T14:06:55Z | |
dc.date.issued | 2023-09-01 | |
dc.identifier | ARTN 100455 | |
dc.identifier.citation | Current Opinion in Biomedical Engineering, 2023, 27 | en_US |
dc.identifier.issn | 2468-4511 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/6083 | |
dc.identifier.doi | 10.1016/j.cobme.2023.100455 | |
dc.identifier.doi | 10.1016/j.cobme.2023.100455 | |
dc.identifier.doi | 10.1016/j.cobme.2023.100455 | |
dc.identifier.doi | 10.1016/j.cobme.2023.100455 | |
dc.language | English | |
dc.language.iso | eng | en_US |
dc.publisher | ELSEVIER | en_US |
dc.relation.ispartof | Current Opinion in Biomedical Engineering | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | en_US |
dc.subject | Science & Technology | |
dc.subject | Technology | |
dc.subject | Engineering, Biomedical | |
dc.subject | Engineering | |
dc.subject | Intracellular antibodies | |
dc.subject | iDab | |
dc.subject | Abd technology | |
dc.subject | RAS | |
dc.subject | LMO2 | |
dc.subject | Bio- degrader | |
dc.subject | Warheads | |
dc.subject | PROTAC | |
dc.subject | Drug discovery | |
dc.subject | PROTEIN | |
dc.subject | SELECTION | |
dc.subject | CANCER | |
dc.title | Intracellular antibodies and biodegraders: Beyond small molecules and back again | en_US |
dc.type | Journal Article | |
dcterms.dateAccepted | 2023-03-16 | |
dc.date.updated | 2023-11-30T14:01:37Z | |
rioxxterms.version | AM | en_US |
rioxxterms.versionofrecord | 10.1016/j.cobme.2023.100455 | en_US |
rioxxterms.licenseref.startdate | 2023-09-01 | |
rioxxterms.type | Journal Article/Review | en_US |
pubs.organisational-group | ICR | |
pubs.organisational-group | ICR/Primary Group | |
pubs.organisational-group | ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Chromosomal Translocations and Intracellular Antibody Therapeutics | |
pubs.publication-status | Accepted | |
pubs.publisher-url | http://dx.doi.org/10.1016/j.cobme.2023.100455 | |
pubs.volume | 27 | |
icr.researchteam | Chr Trans & Intra Ab Ther | en_US |
dc.contributor.icrauthor | Rabbitts, Terence | |
icr.provenance | Deposited by Mr Arek Surman on 2023-11-30. Deposit type is initial. No. of files: 1. Files: text COMBE_.pdf | |